Drugs leader

Welcome to the pharmaceutical leader, questions or comments go to medicines leader feedback, thank you for your participation and use.

CMO beach high raw material medicine, "Gold Coast"

In the past the R & D line of least resistance is towards the development of the drug track road, now with the gradual depletion of those compounds, pharmaceutical companies are more challenging to the development of the drug. In view of the cytotoxic drug, prostaglandin, anesthetics, cancer drugs, such as strong demand for high-performance drugs, is pushing for the efficient production facilities, in order to adapt to this situation, the organization is expanding its contract production of the materials used in clinical trials and commercialization aspects of the production Capacity.
...

SFDA: sodium direct cause of the incident is not yet finalized

April 21, 2008, in the United States to attend an international seminar on the heparin Chinese experts in Washington, media interviews, according to the currently available heparin-related adverse events data and report adverse events related to research, and other information, experts believe that the Chinese side In the United States and other countries of the heparin adverse events can not be the direct cause of end-identified as "heparin material" caused. April 2008 17-18, in the United States, Maryland Rockwell held the United States, Australia, Denmark, Germany, France, South Korea, the Netherlands, Canada, Japan, Italy, Singapore, China and other 12 countries and the European Pharmacopoeia will Experts participating in the International Symposium on heparin, the Chinese Ministry of Health and State Food and Drug Administration sent by the clinical medicine, pharmacy, testing, monitoring adverse reactions, such as 7-member delegation of experts attending the meeting on heparin Sodium quality standards, testing methods, test results, clinical adverse events, products and retrospective sodium efficient product supply issues, such as extensive and in-depth discussion.
...

In 2007, 16 city hospitals sample analysis of the anti-ulcer drug

In the living environment of change, irregular eating, as well as excessive drinking, smoking and other reasons under the influence of peptic ulcer disease has gradually increased. According to relevant statistics, among the crowd of peptic ulcer detection rate of 16% to 33% within one year recurrence rate of 60% to 80%. 3, the last 16 years, the city hospital's drug sample shows that peptic ulcer medication in the hospital a substantial increase in the use of. Proton pump inhibitor pilot
...

Cardiovascular drug was optimistic about the prospects of calcium antagonists have a follow-up "medicine"

Cardiovascular disease in all types of the disease is higher prevalence, treatment of a class of difficult. With the social development and human way of life changes, the development of the situation becoming increasingly prominent. Has been referred to as "a threat to human health in the first killer."
...

ω-3 fatty acids to rectify the challenges facing the industry has to wind and rain

Market research agency F & S said the company in the near future, as there is scientific evidence that fatty acids benefit the heart health and therefore, ω-3 fatty acids on the market is becoming the most popular one of the raw materials, the market size is estimated to more than 130,000,000 pounds, However, profitable ω-3 fatty acid industry, and its future development will face a major challenge, and that is to start on the ω-3 fatty acids to distinguish between the types of conduct.
...

South Africa will start PREVENAR into the child immunization program

Wyeth's Wyeth Pharmaceutical Co., Ltd. announced today that South Africa has been dependent on a PREVENAR start against pneumococcal disease immunization programs, PREVENAR is a vaccine to help infants and children caused by the world's most against pneumococcal disease 7 vaccines sera. Last week, the South African government in the Eastern Cape Province of zone uka Lamba start the pneumococcal disease immunization programs and plans by the end of March 2009 before the nationwide promotion of the project.
...
Page:[«]1[2][3][»]

Calendar

<< 2008-9 >>

Sun

Mon

Tue

Wed

Thu

Fri

Sat

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

Drugs leader

Comments

Lately left messages

Latest Trackback

Search

Blog Statistics

  • Amount of articles:14
  • Amount of comments:0
  • Amount of Trackbacks:0
  • Number of browse times:23
  • Amount of left word:0
  • Current theme:Default
  • Current style:default

Favorites

Misc

  • RainbowSoft Studio Z-Blog
  • RainbowSoft Studio Z-Blog
  • Site visits to support WAP
  • Subscribe the RSS 2.0 news aggregator

Powered By Z-Blog 1.8 Spirit Build 80722 Code detection by Codefense

Copyright www.jiankang160.com Your WebSite. Some Rights Reserved.